A New Mutational and Epigenetic Signature to Predict Early OPSCC Relapse
Clinical trial NCT06138483 · UNKNOWN
Trial details
- NCT number
- NCT06138483
- Sponsor
- Centro di Riferimento Oncologico - Aviano
- Status
- UNKNOWN
- Study type
- OBSERVATIONAL
- Start date
- 2019-04-19
- Primary completion
- 2024-06-30
- Enrollment
- 267
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.